{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Based on the findings reported in"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", LINC00605 was identified as one of a panel of cancer‐specific long non‑coding RNAs significantly associated with overall survival in ovarian cancer patients. In this study, gene co‑expression network analyses—integrating competing endogenous RNA (ceRNA) and RNA binding protein‑mRNA interactions—revealed that LINC00605 is implicated in the molecular pathways underlying tumorigenesis. Its altered expression, as part of the identified lncRNA module, correlates with key clinical traits such as patient age, lymphatic and vascular invasion, and residual tumor disease, suggesting that LINC00605 may serve as a prognostic biomarker and potential therapeutic target in ovarian cancer.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Na Li, Xianquan Zhan "}, {"type": "b", "children": [{"type": "t", "text": "Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EPMA J (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13167-019-00175-0"}], "href": "https://doi.org/10.1007/s13167-019-00175-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31462944"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31462944"}]}]}]}